CD44 and cancer: In this regard, CD44 represents an HA receptor therapeutically interesting since it is known to be upregulated in cancer-initiating or metastasizing cells, and involved in the epithelial-mesenchymal transition (EMT), cancer cell survival and drug resistance [21, 22].